Dyax Corp

Dyax Corp products

K

• Kalbitor®

  • Generic Name: ecallantide

  • Indication: Treatment of acute attacks of hereditary angioedema (HAE) in patients aged 12 years and older. Delivered via subcutaneous injections.

R

• Ramucirumab (marketed as Cyramza® by Eli Lilly)

  • Indication: Oncology—used for gastric, lung, colorectal cancers, and other malignancies. Dyax receives royalties on sales but does not market the product directly.

D

• DX-2930 (Lanadelumab)

• Status: Investigational (pre-approval at Dyax)

• Indication: Long-term prophylaxis for hereditary angioedema (HAE); administered to reduce attack frequency via monoclonal antibody targeting plasma kallikrein.